ArticleOncoTargets and therapy2016

Risk of venous and arterial thromboembolic events associated with anti-VEGF agents in advanced non-small-cell lung cancer: a meta-analysis and systematic review.

Dianbao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.